Cancer cells often develop resistance to therapies, leading to relapse. Understanding the mechanisms of drug resistance is vital. Research into combination therapies that target multiple pathways simultaneously can be effective. Additionally, monitoring minimal residual disease (MRD) using advanced techniques helps in adjusting treatments promptly.
